|
|
||||||||
1 Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada T6G OK6; and Departments of 2 Neuroscience and 4 Psychology and 3 Division of Biomedical Sciences, University of California, Riverside, California 92521
It has previously been shown that agents
that increase endogenous cAMP elicit robust eating when injected into
the perifornical hypothalamus (PFH) but not when injected into
surrounding brain sites, suggesting that PFH cAMP may play a role in
eating control. We report here that bilateral microinjection of the
adenylyl cyclase activator
7-deacetyl-7-O-(N-methylpiperazino)-
-butyryl-forskolin dihydrochloride (MPB forskolin; 300 nmol/0.3 µl) into the PFH is
sufficient to elicit intense eating (up to 15.7 ± 2.3 g in 2 h) in
satiated rats, without concomitant effects on other behaviors, including gnawing and drinking. In contrast, the inactive analog 1,9-dideoxyforskolin is ineffective, suggesting that the effects of MPB
forskolin are behaviorally selective and pharmacologically specific. We
also show that injection of the protein kinase A inhibitor H-89 (100 nmol) into the PFH reduced MPB forskolin-induced eating by up to 50%.
Collectively, these results suggest that increased cAMP production in a
single brain area may be sufficient to selectively generate a
patterned, goal-oriented behavior by activating cAMP-dependent protein
kinase.
feeding; adenosine 3',5'-cyclic monophosphate; forskolin; protein kinase A
This article has been cited by other articles:
![]() |
A. M. Khan, M. C. Curras, J. Dao, F. A. Jamal, C. A. Turkowski, R. K. Goel, E. R. Gillard, S. D. Wolfsohn, and B. G. Stanley Lateral hypothalamic NMDA receptor subunits NR2A and/or NR2B mediate eating: immunochemical/behavioral evidence Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R880 - R891. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |